AGN News and Press, Allergan plc From 08/02/19

DUBLIN , Aug. 2, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced it will release second quarter 2019 financial results on Tuesday, August 6, 2019 , prior to the open of U.S. financial markets. For additional materials related to Allergan's second quarter resul...

Background Pfizer ( PFE ) is spinning off its Upjohn unit and combining it with generic drugmaker Mylan ( MYL ) to create a giant off-patent group with global annual revenues worth about $20 billion. The all-stock deal will unite former branded blockbusters like Lipitor and Viagra with Myl...

(Sourced from ObsEva Website) In a previous article I introduced my readers to a Swiss based biotech—Idorsia ( OTCPK:IDRSF ). With this article I wish to share another Swiss based company, where I think they also would make a great investment for one’s stock portfolio. The ...

DUBLIN , July 29, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) announced today a partnership with actress, musician and producer Ashley Tisdale , bringing awareness to the digital-first 'Women Who Know' campaign that inspires women who are writing their own futures to take charge of the...

Introduction - a story that could once be told simply In this article, I will discuss some of the major points in my understanding of the AbbVie ( ABBV ) story, beginning in early 2017. There is much more to the ABBV story than time permits reviewing, and because the Allergan ( AGN ) deal is...

By a 19-9 vote, the Prescription Drug Pricing Reduction Act has advanced out of the Senate Finance Committee and will go before the full Senate this fall. The bill would cap out-of-pocket costs for medicines at $3,100 per year for Medicare beneficiaries beginning in 2022 and require drug m...

Expect first patient dosing in second half of 2019 DUBLIN, Ireland and CAMBRIDGE, Mass., July 25, 2019 (GLOBE NEWSWIRE) -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, and Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced the ...

As a precaution, Allergan (NYSE: AGN ) is voluntarily recalling its BIOCELL textured breast implants and tissue expanders worldwide in response to global safety information about the rare risk of breast implant-associated anaplastic large cell lymphoma. More news on: Allergan plc, Health...

Allergan Voluntarily Recalls BIOCELL® Textured Breast Implants and Tissue Expanders Canada NewsWire DUBLIN, July 24, 2019 -- Global Action Follows Notification of Updated Safety Information from the U.S. Food and Drug Administration (FDA) --  -- FDA Does No...

As an income and dividend growth investor, I do love dividends, and so do many other investors. Not only do dividends provide a substantial part of overall total return, but they also provide passive income that you can either use to replace existing expenses or, even better, reinvest into you...